































































































































































































































































































































































































































































































































































































































































































































































































































BCVA	 	 	 Best	corrected	visual	acuity	
	
BPE	 	 	 Bovine	pituitary	extract	
	
BSA	 	 	 Bovine	serum	albumin	
	
CK	 	 	 Cytokeratin	
	




DMSO	 	 	 Dimethyl	sulphoxide	
	
DNA	 	 	 Deoxyribonucleic	acid		
	
ECM	 	 	 Extracellular	matrix	
	
EDTA	 	 	 Ethylenediaminetetraacetic	acid	
	
EGF																				 	 Epidermal	growth	factor	 	
	











































SCCM	 	 	 Standard	cubic	centimetres	per	minute	
	
SDS	 	 	 Sodium	dodecyl	sulfate	
	
TRIS	 	 	 2-Amino-2-hydroxymethyl-propane-1,3-diol	
	
TBS	 	 	 Tris	buffered	saline		
	






VA	 	 	 Visual	acuity	
	
















































































































































































































































































































































































































































Supportive	therapy			 	 	 Restoration	
	
-Treatment	of	associated	ocular	surface	disease	 					-	Correction	of	lid	malposition	
-Treatment	of	dry	eye		 	 	 	 					-	Fornix	reconstruction		
-Treatment	of	trichiasis	 	 	 																		-	Conjunctival	replacement		
-Treatment	of	persistent	epithelial	defects	 	 					-	Limbal	stem	cell	transplant	







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Antibody	 Clone	 Supplier	 Dilution	
CK19	 Ab52625	 Abcam	 1:100	
CK7	 RCK105	 Abcam	 1:100	
CK4	 6B10	 Abcam	 1:50	




p63	 ΔN	 Biolegend	 1:50	














































































































































































































































































Antibody	 Clone	 Supplier	 Dilution	
CK19	 Ab52625	 Abcam	 1:400	
CK7	 RCK105	 Abcam	 1:500	
CK4	 6B10	 Abcam	 1:200	
ABCG2	 BXP-21	 Millipore	 1:50	
p63	 ΔN	 Biolegend	 1:50	
Caspase-3	 CPP-32	 Cell	Signalling	 1:50	
PCNA	 PC10	 Santacruz	 1:50	
Laminin	 L9393	 Sigma	 1:200	
Fibronectin	 F3648	 Sigma	 1:250	











































































































































	 N	 Minimum	 Maximum	 Mean	 +/-SD	
Untreated	
ePTFE	















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Donor	number	 Gender	 Age	 Time	to	retrieval	(hours)	
1,	2	 Male	 84	 19	
3,	4	 Male	 87	 7	
5,	6	 Female	 96	 29	
7,	8	 Male	 76	 26	
9,	10	 Female	 80	 16	
11,	12	 Female	 90	 12	
13,	14	 Male	 92	 24	
15,	16	 Male	 77	 9	
17,	18	 Female	 88	 19	
19,	20	 Female	 65	 23	
21,	22	 Female	 85	 																					28	
23,	24	 Male	 84	 22	



















































1:100,	30	minutes	 1:500,	30	minutes	 1:1000,	30	minutes	 1:2000,	30	minutes	
b)	




































































































































































































CK4	 0.22	(0.07)	 0.23	(0.09)	 0.89	
CK7	 2.63	(0.78)	 2.58	(1.11)	 0.95	
CK19	 								98.8	(0.61)	 									99.1	(0.21)	 0.47	
MUC5AC	 0.18	(0.04)	 0.17(0.08)	 0.87	
Lectin	 								44.59	(2.61)	 										46.3	(3.35)	 0.52	
Np63	 									54.9	(11.2)	 										53	(15.6)	 0.78	




Caspase3	 	0.15	(0.03)	 0.12	(0.03)	 0.41	





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Cellular	control	 54.5	 (10.4)	 -	
0.05%	 		0.4	 		(0.2)	 99.3	
0.1%	 		0.2		 		(0.1)	 99.7	













Donor	a	 		0.4	 	(0.2)	 98.9	
Donor	b		 		0.3	 	(0.1)	 99.2	

























































































































































































































































































































































































































































































































































































































































































Rowsey	(score/45)	 22;	24	 16;	19	 29;	36	 14;	29	 28;	45	













Cornea	 	 	 	 	 	
Oxford	dryness	score	 2;	2		 1;	1	 2;	2	 2;	1		 1;	2	
Conjunctivalisation/	
neovascularisation	
1/1;	1/0	 1/0;	1/0	 0/0;	1;0	 1/1;	0/0	 1/0;	0/0	
Opacification	
peripheral/central	
0/0;	0;0	 0/0;	0/0	 0/0;	0/0	 1/0;	0/0	 1/0;	0/0	
LIDS	 	 	 	 	 	
Lagophthalmos	 n;	n	 n;	n	 n;	n	 n;	n	 n;	n	
Lashes	 T;	T	 T;	n	 T;		T	 T;	T	 T;	n	
Upper	lid	deformity	
and	grade	






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































	Total	score	 …………			 	 	 Total	score	 …………	
	
	























































































RE	 Upper	 														mm	 LE	 Upper	 													mm	











	 	 Grade	0	 Grade	1	 Grade	2	 Grade	3	
RE	 Conjunctivalisation	 	 	 	 	
	 Neovascularisation	 	 	 	 	
	 Opacification-	
peripheral		
	 	 	 	
	 Opacification-	
central	
	 	 	 	
	 	 	 	 	 	
LE	 Conjunctivalisation	 	 	 	 	
	 Neovascularisation	 	 	 	 	
	 Opacification-	
peripheral		
	 	 	 	
	 Opacification-	
central	

















Lagophthalmos	 	 Y				……mm	 N				……mm	
	
	












	 Upper	lid			 Lower	lid	 Upper	lid	 Lower	lid	
Grade	0	 	 	 	 	
Grade	1	 	 	 	 	
Grade	2	 	 	 	 	
Grade	3	 	 	 	 	
	 	 	 	 	
Medial	 	 	 	 	
Lateral	 	 	 	 	
Lateral	+	
Medial	
	 	 	 			
	 229	
	 230		
	 231	
	 232	
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